BioSpace News Archive

Drug Development

Pfizer’s Solid Phase III Data; Alnylam and Ionis Shares Fall

Pfizer could be eying the green light for a first-ever regulatory approved treatment for transthyretin cardiomyopathy (TTR) following positive topline results from a late-stage study.

March 30, 2018
·
2 min read
·
Alex Keown
Deals

Walmart Could be Eying a Deal to Acquire Humana

Another major healthcare buyout may be on the horizon. According to reports, Walmart may be in talks to buy health insurer Humana.

March 30, 2018
·
2 min read
·
Alex Keown
FDA

FDA Gives Amgen’s sBLA for Blincyto the Green Light for ALL

The U.S. Food and Drug Administration (FDA) approved Amgen’s supplemental Biologic License Application (sBLA) for Blincyto (blinatumomab) to treat adults and children with B-cell precursor acute lymphoblastic leukemia (ALL) under specific circumstances.

March 30, 2018
·
3 min read
·
Mark Terry
Drug Development

Sunovion Submits NDA for Sublingual Parkinson’s Treatment

Sunovion Pharmaceuticals announced it submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for apomorphine sublingual film to treat OFF episodes in Parkinson’s disease (PD).

March 30, 2018
·
2 min read
·
Mark Terry
Genetown

Researchers Develop Possible New RNA Therapy for West Nile Virus

A research group at Yale University and from Hanyang University, South Korea, developed a new RNA therapy for West Nile Virus. The findings, which were studied in mice, was published in Cell Host & Microbe.

March 30, 2018
·
2 min read
·
Mark Terry
Business

New CDC Director Pledges to Take on AIDS and Opioid Epidemics

Days after being tapped to helm the U.S. Centers for Disease Control and Prevention, Dr. Robert Redfield predicted the AIDs epidemic can be defeated within the next three to seven years and the challenges of the opioid crisis can also be brought “to its knees.”

March 30, 2018
·
2 min read
·
Alex Keown
Business

US Bioservices Executive Joins Board of Directors for National Association of Specialty Pharmacy

National Association of Specialty Pharmacy (NASP) announced the addition of healthcare veteran Kevin James, RPh, MBA to its governing board of directors

March 30, 2018
·
3 min read
Deals

genae Buys Hilbert Paradox

HPX offers a unique way of capturing and correlating digital health data by employing computing power, AI and data analytics.

March 30, 2018
·
1 min read
Biotech Bay

Epic Sciences and Genomic Health Announce Favorable Draft Local Coverage Determination (LCD) on Medicare Coverage for Use of the Oncotype DX® AR-V7 Nucleus Detect™ Test in Patients with Metastatic Castration-Resistant Prostate Cancer

Medicare Draft Coverage Supports Clinical Utility of the Oncotype DX AR-V7 Nucleus Detect Test, Providing 25,000 Medicare Patients with Coverage Once LCD Is Finalized

March 30, 2018
·
6 min read
FDA

Sunovion Submits New Drug Application to the FDA for Apomorphine Sublingual Film (APL-130277) for the Treatment of OFF Episodes Associated with Parkinson’s Disease

Submission is supported by Phase 3 clinical study data showing that the investigational medicine demonstrated superior efficacy versus placebo for the on-demand treatment of OFF episodes associated with Parkinson’s disease.

March 30, 2018
·
7 min read